Partner molecules of accessory protein Vpr of the Human Immunodeficiency Virus type 1

DNA and Cell Biology

Volumn 23, Issue 4, 2004, Pages 193-205

  Kino, Tomoshige ^a,b   Pavlakis, George N ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLOPHILIN A; GAG PROTEIN; GLUCOCORTICOID RECEPTOR; PROTEIN 14 3 3; PROTEIN P300; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VIRUS PROTEIN; VPR PROTEIN;

ALPHA HELIX; AMINO TERMINAL SEQUENCE; APOPTOSIS; CARBOXY TERMINAL SEQUENCE; CELL CYCLE; CELL CYCLE G2 PHASE; CELL FUNCTION; CONFERENCE PAPER; GENE ACTIVATION; HOST CELL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNE RESPONSE; METAPHASE; MITOSIS INHIBITION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN STRUCTURE; TRANSCRIPTION INITIATION; VIRION; VIRUS REPLICATION; VIRUS VIRULENCE;

AMINO ACID SEQUENCE; CELL CYCLE PROTEINS; GENE PRODUCTS, GAG; GENE PRODUCTS, VPR; HIV-1; HUMANS; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, GLUCOCORTICOID; TRANS-ACTIVATORS; TRANSCRIPTION FACTOR TFIIB; TRANSCRIPTION FACTORS; VIRUS ASSEMBLY; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES; SIMIAE; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 2342650905     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/104454904773819789     Document Type: Conference Paper

References (112)

1. AGOSTINI, I., NAVARRO, J.M., REY, F., BOUHAMDAN, M., SPIRE, B., VIGNE, R., and SIRE, J. (1996). The human immunodeficiency virus type 1 Vpr transactivator: Cooperation with promoter-bound activator domains and binding to TFIIB. J. Mol. Biol. 261, 599-606.
2. ALBRIGHT, A.V., SOLDAN, S.S., and GONZALEZ-SCARANO, F. (2003). Pathogenesis of human immunodeficiency virus-induced neurological disease. J. Neurovirol. 9, 222-227.
3. AYYAVOO, V., MAHBOUBI, A., MAHALINGAM, S., RAMALINGAM, R., KUDCHODKAR, S., WILLIAMS, W.V., GREEN, D.R., and WEINER, D.B. (1997). HIV-1 Vpr suppresses immune activation and apoptosis through regulation of nuclear factor kappa B. Nat. Med. 3, 1117-1123.
4. BACHAND, F., YAO, X.J., HRIMECH, M., ROUGEAU, N., and COHEN, E.A. (1999). Incorporation of Vpr into human immunodeficiency virus type 1 requires a direct interaction with the p6 domain of the p55 gag precursor. J. Biol. Chem. 274, 9083-9091.
5. BOUHAMDAN, M., BENICHOU, S., REY, F., NAVARRO, J.M., AGOSTINI, I., SPIRE, B., CAMONIS, J., SLUPPHAUG, G., VIGNE, R., BENAROUS, R., et al. (1996). Human immunodeficiency virus type 1 Vpr protein binds to the uracil DNA glycosylase DNA repair enzyme. J. Virol. 70, 697-704.
6. BOUHAMDAN, M., XUE, Y., BAUDAT, Y., HU, B., SIRE, J., POMERANTZ, R.J., and DUAN, L.X. (1998). Diversity of HIV-1 Vpr interactions involves usage of the WXXF motif of host cell proteins. J. Biol. Chem. 273, 8009-8016.
7. BRUNS, K., FOSSEN, T., WRAY, V., HENKLEIN, P., TESSMER, U., and SCHUBERT, U. (2003). Structural characterization of the HIV-1 Vpr N terminus: Evidence of cis/trans-proline isomerism. J. Biol. Chem. 278, 43188-43201.
8. CHAN, T.A., HERMEKING, H., LENGAUER, C., KINZLER, K.W., and VOGELSTEIN, B. (1999). 14-3-3Sigma is required to prevent mitotic catastrophe after DNA damage. Nature 401, 6161-620.
9. CHEN, L., LIU, T.H., and WALWORTH, N.C. (1999). Association of Chk1 with 14-3-3 proteins is stimulated by DNA damage. Genes Dev. 13, 675-685.
10. COHEN, E.A., DEHNI, G., SODROSKI, J.G., and HASELTINE, W.A. (1990a). Human immunodeficiency virus vpr product is a virion-associated regulatory protein. J. Virol. 64, 3097-3099.
11. COHEN, E.A., SUBBRAMANIAN, R.A., and GOTTLINGER, H.G. (1996). Role of auxiliary proteins in retroviral morphogenesis. Curr. Top. Microbiol. Immunol. 214, 219-235.
12. COHEN, E.A., TERWILLIGER, E.F., JALINOOS, Y., PROULX, J., SODROSKI, J.G., and HASELTINE, W.A. (1990b). Identification of HIV-1 vpr product and function. J. Acquir. Immune Defic. Syndr. 3, 11-18.
13. CONNOR, R.I., CHEN, B.K., CHOE, S., and LANDAU, N.R. (1995). Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes. Virology 206, 935-944.
14. DALAL, S.N., SCHWEITZER, C.M., GAN, J., and DECAPRIO, J.A. (1999). Cytoplasmic localization of human cdc25C during interphase requires an intact 14-3-3 binding site. Mol. Cell Biol. 19, 4465-4479.
15. DE ROCQUIGNY, H., PETITJEAN, P., TANCHOU, V., DECIMO, D., DROUOT, L., DELAUNAY, T., DARLIX, J.L., and ROQUES, B.P. (1997). The zinc fingers of HIV nucleocapsid protein NCp7 direct interactions with the viral regulatory protein Vpr. J. Biol. Chem. 272, 30753-30759.
16. DI MARZIO, P., CHOE, S., EBRIGHT, M., KNOBLAUCH, R., and LANDAU, N.R. (1995). Mutational analysis of cell cycle arrest, nuclear localization and virion packaging of human immunodeficiency virus type 1 Vpr. J. Virol. 69, 7909-7916.
17. DIECKMANN, T., WITHERS-WARD, E.S., JAROSINSKI, M.A., LIU, C.F., CHEN, I.S., and FEIGON, J. (1998). Structure of a human DNA repair protein UBA domain that interacts with HIV-1 Vpr. Nat. Struct. Biol. 5, 1042-1047.
18. ELDER, R.T., YU, M., CHEN, M., EDELSON, S., and ZHAO, Y. (2000). Cell cycle G2 arrest induced by HIV-1 Vpr in fission yeast (Schizosaccharomyces pombe) is independent of cell death and early genes in the DNA damage checkpoint. Virus Res. 68, 161-173.
19. ELDER, R.T., YU, M., CHEN, M., ZHU, X., YANAGIDA, M., and ZHAO, Y. (2001). HIV-1 Vpr induces cell cycle G2 arrest in fission yeast (Schizosaccharomyces pombe) through a pathway involving regulatory and catalytic subunits of PP2A and acting on both Weel and Cdc25. Virology 287, 359-370.
20. EMERMAN, M. (1996). HIV-1, Vpr and the cell cycle. Curr. Biol. 6, 1096-1103.
21. FORGET, J., YAO, X.J., MERCIER, J., and COHEN, E.A. (1998). Human immunodeficiency virus type 1 vpr protein transactivation function: Mechanism and identification of domains involved. J. Mol. Biol. 284, 915-923.
22. FU, H., SUBRAMANIAN, R.R., and MASTERS, S.C. (2000). 14-3-3 Proteins: Structure, function, and regulation. Annu. Rev. Pharmacol. Toxicol. 40, 617-647.
23. GIBBS, J.S., LACKNER, A.A., LANG, S.M., SIMON, M.A., SEHGAL, P.K., DANIEL, M.D., and DESROSIERS, R.C. (1995). Progression to AIDS in the absence of a gene for vpr or vpx. J. Virol. 69, 2378-2383.
24. GOH, W.C., ROGEL, M.E., KINSEY, C.M., MICHAEL, S.F., FULTZ, P.N., NOWAK, M.A., HAHN, B.H., and EMERMAN, M. (1998). HIV-1 Vpr increases viral expression by manipulation of the cell cycle: A mechanism for selection of Vpr in vivo. Nat. Med. 4, 65-71.
25. GOODMAN, R.H., and SMOLIK, S. (2000). CBP/p300 in cell growth, transformation, and development. Genes Dev. 14, 1553-1577.
26. GRAGEROV, A., KINO, T., ILYINA-GRAGEROVA, G., CHROUSOS, G.P., and PAVLAKIS, G.N. (1998). HHR23A, the human homologue of the yeast repair protein RAD23, interacts specifically with Vpr protein and prevents cell cycle arrest but not the transcriptional effects of Vpr. Virology 245, 323-330.
27. GRAVES, P.R., LOVLY, C.M., UY, G.L., and PIWNICA-WORMS, H. (2001). Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding. Oncogene 20, 1839-1851.
28. HAFFAR, O.K., POPOV, S., DUBROVSKY, L., AGOSTINI, I., TANG, H., PUSHKARSKY, T., NADLER, S.G., and BUKRINSKY, M. (2000). Two nuclear localization signals in the HIV-1 matrix protein regulate nuclear import of the HIV-1 pre-integration complex. J. Mol. Biol. 299, 359-368.
29. HE, J., CHOE, S., WALKER, R., DI MARZIO, P., MORGAN, D.O., and LANDAU, N.R. (1995). Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity. J. Virol. 69, 6705-6711.
30. HEINZINGER, N.K., BUKINSKY, M.I., HAGGERTY, S.A., RAGLAND, A.M., KEWALRAMANI, V., LEE, M.A., GENDELMAN, H.E., RATNER, L., STEVENSON, M., and EMERMAN, M. (1994). The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc. Natl. Acad. Sci. USA 91, 7311-7315.
31. HRIMECH, M., YAO, X.J., BACHAND, F., ROUGEAU, N., and COHEN, E.A. (1999). Human immunodeficiency virus type 1 (HIV-1) Vpr functions as an immediate-early protein during HIV-1 infection. J. Virol. 73, 4101-4109.
32. JACKMAN, M.R., and PINES, J.N. (1997). Cyclins and the G2/M transition. Cancer Surv. 29, 47-73.
33. JACOTOT, E., FERRI, K.F., EL HAMEL, C., BRENNER, C., DRUILLENNEC, S., HOEBEKE, J., RUSTIN, P., METIVIER, D., LENOIR, C., GEUSKENS, M., et al. (2001). Control of mitochondrial membrane permeabilization by adenine nucleotide translocator interacting with HIV-1 viral protein R and Bcl-2. J. Exp. Med. 193, 509-519.
34. JACOTOT, E., RAVAGNAN, L., LOEFFLER, M., FERRI, K.F., VIEIRA, H.L., ZAMZAMI, N., COSTANTINI, P., DRUILLENNEC, S., HOEBEKE, J., BRIAND, J.P., et al. (2000). The HIV-1 viral protein R induces apoptosis via a direct effect on the mitochondrial permeability transition pore. J. Exp. Med. 191, 33-46.
35. JENKINS, Y., PORNILLOS, O., RICH, R.L., MYSZKA, D.G., SUNDQUIST, W.I., and MALIM, M.H. (2001). Biochemical analyses of the interactions between human immunodeficiency virus type 1 Vpr and p6(Gag). J. Virol. 75, 10537-10542.
36. JIAN, H., and ZHAO, L.J. (2003). Pro-apoptotic activity of HIV-1 auxiliary regulatory protein Vpr is subtype-dependent and potently enhanced by nonconservative changes of the leucine residue at position 64. J. Biol. Chem. 278, 44326-44330.
37. JOWETT, J.B., PLANELLES, V., POON, B., SHAH, N.P., CHEN, M.L., and CHEN, I.S. (1995). The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle. J. Virol. 69, 6304-6313.
38. KINO, T., and CHROUSOS, G.P. (2003). AIDS-related insulin resistance and lipodystrophy syndrome. Curr. Drug Targets Immune Endocr. Metabol. Disord. 3, 111-117.
39. KINO, T., GRAGEROV, A., KOPP, J.B., STAUBER, R.H., PAVLAKIS, G.N., and CHROUSOS, G.P. (1999). The HIV-1 virion-associated protein vpr is a coactivator of the human glucocorticoid receptor. J. Exp. Med. 189, 51-62.
40. KINO, T., GRAGEROV, A., SLOBODSKAYA, O., TSOPANOMICHALOU, M., CHROUSOS, G.P., and PAVLAKIS, G.N. (2002). Human immunodeficiency virus type-1 accessory protein Vpr induces transcription of the HIV-1 and glucocorticoid-responsive promoters by binding directly to p300/CBP coactivators. J. Virol. 76, 9724-9734.
41. KINO, T., GRAGEROV, A., VALENTIN, A., TSOPANOMICHALOU, M., GRAGEROVA, G.I., ERWIN-COHEN, R., CHROUSOS, G.P., and PAVLAKIS, G.N. (2004). Vpr protein of Human Immunodeficiency Virus Type 1 binds to 14-3-3 proteins and facilitates complex formation with Cdc25C: Implications for cell cycle arrest. submitted.
42. KINO, T., SOUVATZOGLOU, E., DE MARTINO, M.U., TSOPANOMIHALU, M., WAN, Y., and CHROUSOS, G.P. (2003). Protein 14-3-3sigma interacts with and favors cytoplasmic subcellular localization of the glucocorticoid receptor, acting as a negative regulator of the glucocorticoid signaling pathway. J. Biol. Chem. 278, 25651-25656.
43. KONDO, E., and GOTTLINGER, H.G. (1996). A conserved LXXLF sequence is the major determinant in p6gag required for the incorporation of human immunodeficiency virus type 1 Vpr. J. Virol. 70, 159-164.
44. KONDO, E., MAMMANO, F., COHEN, E.A., and GOTTLINGER, H.G. (1995). The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles. J. Virol. 69, 2759-2764.
45. LARONGA, C., YANG, H.Y., NEAL, C., and LEE, M.H. (2000). Association of the cyclin-dependent kinases and 14-3-3 sigma negatively regulates cell cycle progression. J. Biol. Chem. 275, 23106-23112.
46. LEE, I., KUMAGAI, A., and DUNPHY, W.G. (2001). Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. Mol. Biol. Cell 12, 551-563.
47. LEVY, D.N., REFAELI, Y., MACGREGOR, R.R., and WEINER, D.B. (1994). Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 91, 10873-10877.
48. LI, M.S., GARCIA-ASUA, G., BHATTACHARYYA, U., MASCAGNI, P., AUSTEN, B.M., and ROBERTS, M.M. (1996). The Vpr protein of human immunodeficiency virus type 1 binds to nucleocapsid protein p7 in vitro. Biochem. Biophys. Res. Commun. 218, 352-355.
49. LOPEZ-GIRONA, A., FURNARI, B., MONDESERT, O., and RUSSELL, P. (1999). Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein. Nature 397, 172-175.
50. LU, Y.L., BENNETT, R.P., WILLS, J.W., GORELICK, R., and RATNER, L. (1995). A leucine triplet repeat sequence (LXX)4 in p6gag is important for Vpr incorporation into human immunodeficiency virus type 1 particles. J. Virol. 69, 6873-6879.
51. LU, Y.L., SPEARMAN, P., and RATNER, L. (1993). Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J. Virol. 67, 6542-6550.
52. LUM, J.J., COHEN, O.J., NIE, Z., WEAVER, J.G., GOMEZ, T.S., YAO, X.J., LYNCH, D., PILON, A.A., HAWLEY, N., KIM, J.E., et al. (2003). Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J. Clin. Invest. 111, 1547-1554.
53. MAHALINGAM, S., AYYAVOO, V., PATEL, M., KEBER-EMMONS, T., KAO, G.D., MUSCHEL, R.J., and WEINER, D.B. (1998). HIV-1 Vpr interacts with a human 34-kDa mov34 homologue, a cellular factor linked to the G2/M phase transition of the mammalian cell cycle. Proc. Natl. Acad. Sci. USA 95, 3419-3424.
54. MAHALINGAM, S., AYYAVOO, V., PATEL, M., KIEBER-EMMONS, T., and WEINER, D.B. (1997). Nuclear import, virion incorporation, and cell cycle arrest/differentiation are mediated by distinct functional domains of human immunodeficiency virus type 1 Vpr. J. Virol. 71, 6339-6347.
55. MAHALINGAM, S., KHAN, S.A., JABBAR, M.A., MONKEN, C.E., COLLMAN, R.G., and SRINIVASAN, A. (1995a). Identification of residues in the N-terminal acidic domain of HIV-1 Vpr essential for virion incorporation. Virology 207, 297-302.
56. MAHALINGAM, S., KHAN, S.A., MURALI, R., JABBAR, M.A., MONKEN, C.E., COLLMAN, R.G., and SRINIVASAN, A. (1995b). Mutagenesis of the putative alpha-helical domain of the Vpr protein of human immunodeficiency virus type 1: Effect on stability and virion incorporation. Proc. Natl. Acad. Sci. USA 92, 3794-3978.
57. MAHALINGAM, S., PATEL, M., COLLMAN, R.G., and SRINIVASAN, A. (1995c). The carboxy-terminal domain is essential for stability and not for virion incorporation of HIV-1 Vpr into virus particles. Virology 214, 647-652.
58. MANSKY, L.M., PREVERAL, S., LE ROUZIC, E., BERNARD, L.C., SELIG, L., DEPIENNE, C., BENAROUS, R., and BENICHOU, S. (2001). Interaction of human immunodeficiency virus type 1 Vpr with the HHR23A DNA repair protein does not correlate with multiple biological functions of Vpr. Virology 282, 176-185.
59. MANSKY, L.M., PREVERAL, S., SELIG, L., BENAROUS, R., and BENICHOU, S. (2000). The interaction of vpr with uracil DNA glycosylase modulates the human immunodeficiency virus type 1 In vivo mutation rate. J. Virol. 74, 7039-7047.
60. MASUDA, M., NAGAI, Y., OSHIMA, N., TANAKA, K., MURAKAMI, H., IGARASHI, H., and OKAYAMA, H. (2000). Genetic studies with the fission yeast Schizosaccharomyces pombe suggest involvement of weel, ppa2, and rad24 in induction of cell cycle arrest by human immunodeficiency virus type 1 Vpr. J. Virol. 74, 2636-2646.
61. MCKENNA, N.J., XU, J., NAWAZ, Z., TSAI, S.Y., TSAI, M.J., and O'MALLEY, B.W. (1999). Nuclear receptor coactivators: Multiple enzymes, multiple complexes, multiple functions. J. Steroid Biochem. Mol. Biol. 69, 3-12.
62. MORELLET, N., BOUAZIZ, S., PETITJEAN, P., and ROQUES, B.P. (2003). NMR structure of the HIV-1 regulatory protein VPR. J. Mol. Biol. 327, 215-227.
63. MORRIS, M.C., HEITZ, A., MERY, J., HEITZ, F., and DIVITA, G. (2000). An essential phosphorylation-site domain of human cdc25C interacts with both 14-3-3 and cyclins. J. Biol. Chem. 275, 28849-28857.
64. MULLER, B., TESSMER, U., SCHUBERT, U., and KRAUSSLICH, H.G. (2000). Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells. J. Virol. 74, 9727-9731.
65. MUSLIN, A.J., and XING, H. (2000). 14-3-3 Proteins: Regulation of subcellular localization by molecular interference. Cell Signal. 12, 703-709.
66. MUTHUMANI, K., HWANG, D.S., DAYES, N.S., KIM, J.J., and WEINER, D.B. (2002a). The HIV-1 accessory gene vpr can inhibit antigen-specific immune function. DNA Cell Biol. 21, 689-695.
67. MUTHUMANI, K., HWANG, D.S., DESAI, B.M., ZHANG, D., DAYES, N., GREEN, D.R., and WEINER, D.B. (2002b). HIV-1 Vpr induces apoptosis through caspase 9 in T cells and peripheral blood mononuclear cells. J. Biol. Chem. 277, 37820-37831.
68. NEBREDA, A.R., and FERBY, I. (2000). Regulation of the meiotic cell cycle in oocytes. Curr. Opin. Cell Biol. 12, 666-675.
69. NIE, Z., BERGERON, D., SUBBRAMANIAN, R.A., YAO, X.J., CHECROUNE, F., ROUGEAU, N., and COHEN, E.A. (1998). The putative alpha helix 2 of human immunodeficiency virus type 1 Vpr contains a determinant which is responsible for the nuclear translocation of proviral DNA in growth-arrested cells. J. Virol. 72, 4104-4115.
70. NISHIZAWA, M., KAMATA, M., KATSUMATA, R., and AIDA, Y. (2000). A carboxy-terminally truncated form of the human immunodeficiency virus type 1 Vpr protein induces apoptosis via G(1) cell cycle arrest. J. Virol. 74, 6058-6067.
71. OHI, R., and GOULD, K.L. (1999). Regulating the onset of mitosis. Curr. Opin. Cell Biol. 11, 267-273.
72. PATEL, C.A., MUKHTAR, M., and POMERANTZ, R.J. (2000). Human immunodeficiency virus type 1 Vpr induces apoptosis in human neuronal cells. J. Virol. 74, 9717-9726.
73. PAVLAKIS, G.N. (1996). The molecular biology of HIV-1, 4 ed. In AIDS: Diagnosis, Treatment and Prevention V.T. DeVita, S., Hellman, and S.A. Rosenberg, eds. (Lippincott Raven, Philadelphia), pp. 45-74.
74. PAXTON, W., CONNOR, R.I., and LANDAU, N.R. (1993). Incorporation of Vpr into human immunodeficiency virus type 1 virions: Requirement for the p6 region of gag and mutational analysis. J. Virol. 67, 7229-7237.
75. PENG, C.Y., GRAVES, P.R., THOMA, R.S., WU, Z., SHAW, A.S., and PIWNICA-WORMS, H. (1997). Mitotic and G2 checkpoint control: Regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. Science 277, 1501-1505.
76. PILLER, S.C., EWART, G.D., JANS, D.A., GAGE, P.W., and COX, G.B. (1999). The amino-terminal region of Vpr from human immunodeficiency virus type 1 forms ion channels and kills neurons. J. Virol. 73, 4230-4238.
77. PILLER, S.C., JANS, P., GAGE, P.W., and JANS, D.A. (1998). Extracellular HIV-1 virus protein R causes a large inward current and cell death in cultured hippocampal neurons: Implications for AIDS pathology. Proc. Natl. Acad. Sci. USA 95, 4595-4600.
78. POPOV, S., REXACH, M., RATNER, L., BLOBEL, G., and BUKRINSKY, M. (1998a). Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex. J. Biol. Chem. 273, 13347-13352.
79. POPOV, S., REXACH, M., ZYBARTH, G., REILING, N., LEE, M.A., RATNER, L., LANE, C.M., MOORE, M.S., BLOBEL, G., and BUKRINSKY, M. (1998b). Viral protein R regulates nuclear import of the HIV-1 pre-integration complex. EMBO J. 17, 909-917.
80. RAMANATHAN, M.P., CURLEY, E., III, SU, M., CHAMBERS, J.A., and WEINER, D.B. (2002). Carboxyl terminus of hVIP/mov34 is critical for HIV-1-Vpr interaction and glucocorticoid-mediated signaling. J. Biol. Chem. 277, 47854-47860.
81. RE, F., BRAATEN, D., FRANKE, E.K., and LUBAN, J. (1995). Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B. J. Virol. 69, 6859-6864.
82. REFAELI, Y., LEVY, D.N., and WEINER, D.B. (1995). The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proc. Natl. Acad. Sci. USA 92, 3621-3625.
83. RITTINGER, K., BUDMAN, J., XU, J., VOLINIA, S., CANTLEY, L.C., SMERDON, S.J., GAMBLIN, S.J., and YAFFE, M.B. (1999). Structural analysis of 14-3-3 phosphopeptide complexes identifies a dual role for the nuclear export signal of 14-3-3 in ligand binding. Mol. Cell 4, 153-166.
84. ROGEL, M.E., WU, L.I., and EMERMAN, M. (1995). The human immunodeficiency virus type 1 vpr gene prevents cell proliferation during chronic infection. J. Virol. 69, 882-888.
85. ROQUES, B.P., MORELLET, N., DE ROCQUIGNY, H., DEMENE, H., SCHUELER, W., and JULLIAN, N. (1997). Structure, biological functions and inhibition of the HIV-1 proteins Vpr and NCp7. Biochimie 79, 673-680.
86. ROSENQUIST, M., SEHNKE, P., FERL, R.J., SOMMARIN, M., and LARSSON, C. (2000). Evolution of the 14-3-3 protein family: Does the large number of isoforms in multicellular organisms reflect functional specificity? J. Mol. Evol. 51, 446-458.
87. ROUX, P., ALFIERI, C., HRIMECH, M., COHEN, E.A., and TANNER, J.E. (2000). Activation of transcription factors NF-kappaB and NF-IL-6 by human immunodeficiency virus type 1 protein R (Vpr) induces interleukin-8 expression. J. Virol. 74, 4658-4665.
88. SANCHEZ, Y., WONG, C., THOMA, R.S., RICHMAN, R., WU, Z., PIWNICA-WORMS, H., and ELLEDGE, S.J. (1997). Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. Science 277, 1497-1501.
89. SATO, A., YOSHIMOTO, J., ISAKA, Y., MIKI, S., SUYAMA, A., ADACHI, A., HAYAMI, M., FUJIWARA, T., and YOSHIE, O. (1996). Evidence for direct association of Vpr and matrix protein p17 within the HIV-1 virion. Virology 220, 208-212.
90. SAWAYA, B.E., KHALILI, K., GORDON, J., TAUBE, R., and AMINI, S. (2000). Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome. J. Biol. Chem. 275, 35209-35214.
91. SCHULER, W., WECKER, K., DE ROCQUIGNY, H., BAUDAT, Y., SIRE, J., and ROQUES, B.P. (1999). NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr: Molecular insights into its biological functions. J. Mol. Biol. 285, 2105-2117.
92. SELIG, L., BENICHOU, S., ROGEL, M.E., WU, L.I., VODICKA, M.A., SIRE, J., BENAROUS, R., and EMERMAN, M. (1997). Uracil DNA glycosylase specifically interacts with Vpr of both human immunodeficiency virus type 1 and simian immunodeficiency virus of sooty mangabeys, but binding does not correlate with cell cycle arrest. J. Virol. 71, 4842-4846.
93. SHERMAN, M.P., DE NORONHA, C.M., HEUSCH, M.I., GREENE, S., and GREENE, W.C. (2001). Nucleocytoplasmic shuttling by human immunodeficiency virus type 1 Vpr. J. Virol. 75, 1522-1532.
94. STARK, L.A., and HAY, R.T. (1998). Human immunodeficiency virus type 1 (HIV-1) viral protein R (Vpr) interacts with Lys-tRNA synthetase: Implications for priming of HIV-1 reverse transcription. J. Virol. 72, 3037-3044.
95. STEWART, S.A., POON, B., JOWETT, J.B., and CHEN, I.S. (1997). Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71, 5579-5592.
96. STEWART, S.A., POON, B., JOWETT, J.B., XIE, Y., and CHEN, I.S. (1999). Lentiviral delivery of HIV-1 Vpr protein induces apoptosis in transformed cells. Proc. Natl. Acad. Sci. USA 96, 12039-12043.
97. STEWART, S.A., POON, B., SONG, J.Y., and CHEN, I.S. (2000). Human immunodeficiency virus type 1 vpr induces apoptosis through caspase activation. J. Virol. 74, 3105-3111.
98. TUNG, H.Y., DE ROCQUIGNY, H., ZHAO, L.J., CAYLA, X., ROQUES, B.P., and OZON, R. (1997). Direct activation of protein phosphatase-2A0 by HIV-1 encoded protein complex NCp7:vpr. FEBS Lett. 401, 197-201.
99. VODICKA, M.A., KOEPP, D.M., SILVER, P.A., and EMERMAN, M. (1998). HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection. Genes Dev. 12, 175-185.
100. WANG, L., MUKHERJEE, S., JIA, F., NARAYAN, O., and ZHAO, L.J. (1995). Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and transactivation of viral long terminal repeat. J. Biol. Chem. 270, 25564-25569.
101. WANG, Y., JACOBS, C., HOOK, K.E., DUAN, H., BOOHER, R.N., and SUN, Y. (2000). Binding of 14-3-3beta to the carboxyl terminus of Weel increases Weel stability, kinase activity, and G2-M cell population. Cell Growth Differ. 11, 211-219.
102. WECKER, K., and ROQUES, B.P. (1999). NMR structure of the (1-51) N-terminal domain of the HIV-1 regulatory protein Vpr. Eur. J. Biochem. 266, 359-369.
103. WITHERS-WARD, E.S., JOWETT, J.B., STEWART, S.A., XIE, Y.M., GARFINKEL, A., SHIBAGAKI, Y., CHOW, S.A., SHAH, N., HANAOKA, F., SAWITZ, D.G., et al. (1997). Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair. J. Virol. 71, 9732-9742.
104. WITHERS-WARD, E.S., MUELLER, T.D., CHEN, I.S., and FEIGON, J. (2000). Biochemical and structural analysis of the interaction between the UBA(2) domain of the DNA repair protein HHR23A and HIV-1 Vpr. Biochemistry 39, 14103-14112.
105. YAFFE, M.B., RITTINGER, K., VOLINIA, S., CARON, P.R., AITKEN, A., LEFFERS, H., GAMBLIN, S.J., SMERDON, S.J., and CANTLEY, L.C. (1997). The structural basis for 14-3-3:phosphopeptide binding specificity. Cell 91, 961-971.
106. YAO, X.J., SUBBRAMANIAN, R.A., ROUGEAU, N., BOISVERT, F., BERGERON, D., and COHEN, E.A. (1995). Mutagenic analysis of human immunodeficiency virus type 1 Vpr: Role of a predicted N-terminal alpha-helical structure in Vpr nuclear localization and virion incorporation. J. Virol. 69, 7032-7044.
107. YUAN, H., XIE, Y.M., and CHEN, I.S. (2003). Depletion of Wee-1 kinase is necessary for both human immunodeficiency virus type 1 Vpr- and gamma irradiation-induced apoptosis. J. Virol. 77, 2063-2070.
108. ZANDER, K., SHERMAN, M.P., TESSMER, U., BRUNS, K., WRAY, V., PRECHTEL, A.T., SCHUBERT, E., HENKLEIN, P., LUBAN, J., NEIDLEMAN, J., et al. (2003). Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression. J. Biol. Chem. 278, 43202-43213.
109. ZENG, Y., FORBES, K.C., WU, Z., MORENO, S., PIWNICAWORMS, H., and ENOCH, T. (1998). Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1. Nature 395, 507-510.
110. ZHANG, S., POINTER, D., SINGER, G., FENG, Y., PARK, K., and ZHAO, L.J. (1998). Direct binding to nucleic acids by Vpr of human immunodeficiency virus type 1. Gene 212, 157-166.
111. ZHAO, L.J., MUKHERJEE, S., and NARAYAN, O. (1994a). Biochemical mechanism of HIV-1 Vpr function. Specific interaction with a cellular protein. J. Biol. Chem. 269, 15577-15582.
112. ZHAO, L.J., WANG, L., MUKHERJEE, S., and NARAYAN, O. (1994b). Biochemical mechanism of HIV-1 Vpr function. Oligomerization mediated by the N-terminal domain. J. Biol. Chem. 269, 32131-32137.